RU2013105450A - Новые производные гомопиперзина в качестве ингибиторов протеинтирозинкиназ и их фармацевтическое применение - Google Patents
Новые производные гомопиперзина в качестве ингибиторов протеинтирозинкиназ и их фармацевтическое применение Download PDFInfo
- Publication number
- RU2013105450A RU2013105450A RU2013105450/04A RU2013105450A RU2013105450A RU 2013105450 A RU2013105450 A RU 2013105450A RU 2013105450/04 A RU2013105450/04 A RU 2013105450/04A RU 2013105450 A RU2013105450 A RU 2013105450A RU 2013105450 A RU2013105450 A RU 2013105450A
- Authority
- RU
- Russia
- Prior art keywords
- diazaspiro
- pyrrolo
- pyrimidin
- nonan
- methanone
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- -1 cyano, hydroxy Chemical group 0.000 claims abstract 64
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract 40
- 150000001875 compounds Chemical class 0.000 claims abstract 34
- 125000000217 alkyl group Chemical group 0.000 claims abstract 32
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract 31
- 125000004404 heteroalkyl group Chemical group 0.000 claims abstract 27
- 229910052736 halogen Inorganic materials 0.000 claims abstract 18
- 150000002367 halogens Chemical group 0.000 claims abstract 18
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 18
- 239000001257 hydrogen Substances 0.000 claims abstract 18
- 125000004043 oxo group Chemical group O=* 0.000 claims abstract 18
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract 12
- 150000002431 hydrogen Chemical group 0.000 claims abstract 11
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract 3
- 125000003118 aryl group Chemical group 0.000 claims 15
- 125000001072 heteroaryl group Chemical group 0.000 claims 14
- 125000003342 alkenyl group Chemical group 0.000 claims 13
- 125000000304 alkynyl group Chemical group 0.000 claims 12
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 11
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 10
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 10
- 125000003710 aryl alkyl group Chemical group 0.000 claims 9
- 208000023275 Autoimmune disease Diseases 0.000 claims 7
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 125000005160 aryl oxy alkyl group Chemical group 0.000 claims 6
- 125000004104 aryloxy group Chemical group 0.000 claims 6
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 6
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 6
- 206010012438 Dermatitis atopic Diseases 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 201000004681 Psoriasis Diseases 0.000 claims 4
- 201000008937 atopic dermatitis Diseases 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 4
- 125000005326 heteroaryloxy alkyl group Chemical group 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 201000006417 multiple sclerosis Diseases 0.000 claims 4
- 208000017520 skin disease Diseases 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 3
- 206010009900 Colitis ulcerative Diseases 0.000 claims 3
- 208000011231 Crohn disease Diseases 0.000 claims 3
- 201000004624 Dermatitis Diseases 0.000 claims 3
- 208000002249 Diabetes Complications Diseases 0.000 claims 3
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 3
- 241001303601 Rosacea Species 0.000 claims 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 3
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 3
- 125000004946 alkenylalkyl group Chemical group 0.000 claims 3
- 125000005038 alkynylalkyl group Chemical group 0.000 claims 3
- 125000004350 aryl cycloalkyl group Chemical group 0.000 claims 3
- 208000006673 asthma Diseases 0.000 claims 3
- 208000010928 autoimmune thyroid disease Diseases 0.000 claims 3
- 125000005356 cycloalkylalkenyl group Chemical group 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 208000030533 eye disease Diseases 0.000 claims 3
- 125000005114 heteroarylalkoxy group Chemical group 0.000 claims 3
- 125000005349 heteroarylcycloalkyl group Chemical group 0.000 claims 3
- 125000004449 heterocyclylalkenyl group Chemical group 0.000 claims 3
- 210000000987 immune system Anatomy 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 230000002458 infectious effect Effects 0.000 claims 3
- 208000027866 inflammatory disease Diseases 0.000 claims 3
- 208000032839 leukemia Diseases 0.000 claims 3
- 206010025135 lupus erythematosus Diseases 0.000 claims 3
- 208000002780 macular degeneration Diseases 0.000 claims 3
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 3
- 201000004700 rosacea Diseases 0.000 claims 3
- VIJCSROECFZLKA-UHFFFAOYSA-N (5-methyl-1h-pyrazol-3-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound N1N=C(C)C=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 VIJCSROECFZLKA-UHFFFAOYSA-N 0.000 claims 2
- DNLYKIBLZSHIRI-UHFFFAOYSA-N (5-methyl-1h-pyrazol-3-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound N1N=C(C)C=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 DNLYKIBLZSHIRI-UHFFFAOYSA-N 0.000 claims 2
- HIAZHBYRJBITLA-UHFFFAOYSA-N 1h-imidazol-5-yl-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C=1NC=NC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 HIAZHBYRJBITLA-UHFFFAOYSA-N 0.000 claims 2
- ZKZWUNHNOIHYGY-UHFFFAOYSA-N 1h-imidazol-5-yl-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C=1NC=NC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 ZKZWUNHNOIHYGY-UHFFFAOYSA-N 0.000 claims 2
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims 2
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims 2
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 2
- 125000005324 aryloxy alkyloxy group Chemical group 0.000 claims 2
- 208000010668 atopic eczema Diseases 0.000 claims 2
- 125000005357 cycloalkylalkynyl group Chemical group 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 206010023332 keratitis Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 125000006413 ring segment Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000003831 tetrazolyl group Chemical group 0.000 claims 2
- 125000001544 thienyl group Chemical group 0.000 claims 2
- HZMNSCPCLOAADH-UHFFFAOYSA-N (1-phenylcyclopropyl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C1CC1(C=1C=CC=CC=1)C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 HZMNSCPCLOAADH-UHFFFAOYSA-N 0.000 claims 1
- UMZMVIHVPPGAEF-UHFFFAOYSA-N (2,3-dimethoxyphenyl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound COC1=CC=CC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1OC UMZMVIHVPPGAEF-UHFFFAOYSA-N 0.000 claims 1
- CIMQNOZEUKUAPE-UHFFFAOYSA-N (2,5-dimethylpyrazol-3-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound CN1N=C(C)C=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 CIMQNOZEUKUAPE-UHFFFAOYSA-N 0.000 claims 1
- IDVKHQGJCUQGDA-UHFFFAOYSA-N (2,5-dimethylpyrazol-3-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound CN1N=C(C)C=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 IDVKHQGJCUQGDA-UHFFFAOYSA-N 0.000 claims 1
- PUHZAQXQFPAMSD-UHFFFAOYSA-N (2-chlorophenyl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound ClC1=CC=CC=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 PUHZAQXQFPAMSD-UHFFFAOYSA-N 0.000 claims 1
- WIWRPGLMUZSAKL-UHFFFAOYSA-N (2-chlorophenyl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound ClC1=CC=CC=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 WIWRPGLMUZSAKL-UHFFFAOYSA-N 0.000 claims 1
- GWXVWAVDSYEYPS-UHFFFAOYSA-N (2-fluorophenyl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound FC1=CC=CC=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 GWXVWAVDSYEYPS-UHFFFAOYSA-N 0.000 claims 1
- AMUAFMVUIRXNNS-UHFFFAOYSA-N (2-methoxypyridin-3-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound COC1=NC=CC=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 AMUAFMVUIRXNNS-UHFFFAOYSA-N 0.000 claims 1
- CXHTYRFGMIXAFZ-UHFFFAOYSA-N (2-methylphenyl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound CC1=CC=CC=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 CXHTYRFGMIXAFZ-UHFFFAOYSA-N 0.000 claims 1
- AHIYFSIDLZEJPL-UHFFFAOYSA-N (2-methylphenyl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound CC1=CC=CC=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 AHIYFSIDLZEJPL-UHFFFAOYSA-N 0.000 claims 1
- RQVHOQOLHIPUEN-UHFFFAOYSA-N (2-methylpyridin-3-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound CC1=NC=CC=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 RQVHOQOLHIPUEN-UHFFFAOYSA-N 0.000 claims 1
- CZLBVCVCIKFBAJ-UHFFFAOYSA-N (2-methylpyridin-3-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound CC1=NC=CC=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 CZLBVCVCIKFBAJ-UHFFFAOYSA-N 0.000 claims 1
- KJBZCGGZULYOCO-UHFFFAOYSA-N (2-methylpyridin-4-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C1=NC(C)=CC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 KJBZCGGZULYOCO-UHFFFAOYSA-N 0.000 claims 1
- FAAJQZNAGDCIMI-UHFFFAOYSA-N (2-methylpyridin-4-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C1=NC(C)=CC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=C1 FAAJQZNAGDCIMI-UHFFFAOYSA-N 0.000 claims 1
- JDHPUMKMIAARIK-CQSZACIVSA-N (2r)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]pyrrolidine-2-carbonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)N1CCC[C@@H]1C#N JDHPUMKMIAARIK-CQSZACIVSA-N 0.000 claims 1
- JDHPUMKMIAARIK-AWEZNQCLSA-N (2s)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]pyrrolidine-2-carbonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)N1CCC[C@H]1C#N JDHPUMKMIAARIK-AWEZNQCLSA-N 0.000 claims 1
- MLBGYNJQRALAPI-UHFFFAOYSA-N (3,5-dimethoxyphenyl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound COC1=CC(OC)=CC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 MLBGYNJQRALAPI-UHFFFAOYSA-N 0.000 claims 1
- FFCLCQAAWRYFNU-UHFFFAOYSA-N (3,5-dimethyl-1,2-oxazol-4-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound CC1=NOC(C)=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 FFCLCQAAWRYFNU-UHFFFAOYSA-N 0.000 claims 1
- ROIOPWDUNBZLAT-UHFFFAOYSA-N (3,5-dimethyl-1,2-oxazol-4-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound CC1=NOC(C)=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 ROIOPWDUNBZLAT-UHFFFAOYSA-N 0.000 claims 1
- GZBVZGCHDBQKDP-UHFFFAOYSA-N (3-chlorophenyl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound ClC1=CC=CC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 GZBVZGCHDBQKDP-UHFFFAOYSA-N 0.000 claims 1
- CKPWLXQDULJNMK-UHFFFAOYSA-N (3-chlorophenyl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound ClC1=CC=CC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=C1 CKPWLXQDULJNMK-UHFFFAOYSA-N 0.000 claims 1
- SQWISDWIVXFEKR-UHFFFAOYSA-N (3-ethyl-4,5-dihydro-1,2-oxazol-5-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C1C(CC)=NOC1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 SQWISDWIVXFEKR-UHFFFAOYSA-N 0.000 claims 1
- SPAAIIIEXZELRQ-UHFFFAOYSA-N (3-methyl-1,2-oxazol-4-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound CC1=NOC=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 SPAAIIIEXZELRQ-UHFFFAOYSA-N 0.000 claims 1
- CPYRGZVNRRNJIU-UHFFFAOYSA-N (3-methyl-1,2-oxazol-4-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound CC1=NOC=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 CPYRGZVNRRNJIU-UHFFFAOYSA-N 0.000 claims 1
- JQMBCKAMLFJMBB-UHFFFAOYSA-N (3-methyl-1,2-oxazol-5-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound O1N=C(C)C=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 JQMBCKAMLFJMBB-UHFFFAOYSA-N 0.000 claims 1
- RYFRNGJOTICOPE-UHFFFAOYSA-N (3-methyl-1,2-thiazol-5-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound S1N=C(C)C=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 RYFRNGJOTICOPE-UHFFFAOYSA-N 0.000 claims 1
- JXZSVITXTJYYGO-UHFFFAOYSA-N (3-methyl-1,2-thiazol-5-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound S1N=C(C)C=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 JXZSVITXTJYYGO-UHFFFAOYSA-N 0.000 claims 1
- KMEWCPJCUBXZSH-UHFFFAOYSA-N (3-methylimidazol-4-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound CN1C=NC=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 KMEWCPJCUBXZSH-UHFFFAOYSA-N 0.000 claims 1
- HZCASOOJBJYHQL-UHFFFAOYSA-N (3-methylimidazol-4-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound CN1C=NC=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 HZCASOOJBJYHQL-UHFFFAOYSA-N 0.000 claims 1
- QOYZGVMSDVXFLE-UHFFFAOYSA-N (3-methylpyridin-4-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound CC1=CN=CC=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 QOYZGVMSDVXFLE-UHFFFAOYSA-N 0.000 claims 1
- URSLSNQGIZMBSX-UHFFFAOYSA-N (3-methylpyridin-4-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound CC1=CN=CC=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 URSLSNQGIZMBSX-UHFFFAOYSA-N 0.000 claims 1
- CWEMDCYMQJBEIZ-UHFFFAOYSA-N (4-amino-1,2,5-oxadiazol-3-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound NC1=NON=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 CWEMDCYMQJBEIZ-UHFFFAOYSA-N 0.000 claims 1
- FUYSRNWXOSZVMS-UHFFFAOYSA-N (4-chlorophenyl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 FUYSRNWXOSZVMS-UHFFFAOYSA-N 0.000 claims 1
- MKNYWGXTYRTGPU-UHFFFAOYSA-N (4-chlorophenyl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 MKNYWGXTYRTGPU-UHFFFAOYSA-N 0.000 claims 1
- UAPZYDKCISXBMD-UHFFFAOYSA-N (4-fluorophenyl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C1=CC(F)=CC=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 UAPZYDKCISXBMD-UHFFFAOYSA-N 0.000 claims 1
- OZUXIANABJCPAV-UHFFFAOYSA-N (4-methoxythiophen-2-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound COC1=CSC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 OZUXIANABJCPAV-UHFFFAOYSA-N 0.000 claims 1
- WKKDRZOHSVCUTQ-UHFFFAOYSA-N (4-methyl-1,3-oxazol-5-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound N1=COC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1C WKKDRZOHSVCUTQ-UHFFFAOYSA-N 0.000 claims 1
- UKYVCXCVEOAAPZ-UHFFFAOYSA-N (4-methyl-1,3-oxazol-5-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound N1=COC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=C1C UKYVCXCVEOAAPZ-UHFFFAOYSA-N 0.000 claims 1
- YYAMEIPEECDPFU-UHFFFAOYSA-N (4-methyl-1h-pyrrol-2-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound CC1=CNC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=C1 YYAMEIPEECDPFU-UHFFFAOYSA-N 0.000 claims 1
- NFOADZYWXJCNPU-UHFFFAOYSA-N (4-methylpyridin-3-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound CC1=CC=NC=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 NFOADZYWXJCNPU-UHFFFAOYSA-N 0.000 claims 1
- UOIFQHVXTCWLIZ-UHFFFAOYSA-N (4-methylpyridin-3-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound CC1=CC=NC=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 UOIFQHVXTCWLIZ-UHFFFAOYSA-N 0.000 claims 1
- GADMYKNGDQCNQJ-UHFFFAOYSA-N (4-methylthiadiazol-5-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound N1=NSC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1C GADMYKNGDQCNQJ-UHFFFAOYSA-N 0.000 claims 1
- YPDWYVPPLASDMY-UHFFFAOYSA-N (4-methylthiadiazol-5-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound N1=NSC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=C1C YPDWYVPPLASDMY-UHFFFAOYSA-N 0.000 claims 1
- GHBSEPZTCBOPRV-UHFFFAOYSA-N (5-chloro-1h-1,2,4-triazol-3-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound N1C(Cl)=NC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=N1 GHBSEPZTCBOPRV-UHFFFAOYSA-N 0.000 claims 1
- YUYUHOLHMDENDF-UHFFFAOYSA-N (5-chloro-1h-1,2,4-triazol-3-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound N1C(Cl)=NC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=N1 YUYUHOLHMDENDF-UHFFFAOYSA-N 0.000 claims 1
- QNPUUVINTOITBB-UHFFFAOYSA-N (5-fluoropyridin-3-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound FC1=CN=CC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 QNPUUVINTOITBB-UHFFFAOYSA-N 0.000 claims 1
- XLJZXACOKNMACD-UHFFFAOYSA-N (5-fluoropyridin-3-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound FC1=CN=CC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=C1 XLJZXACOKNMACD-UHFFFAOYSA-N 0.000 claims 1
- AFVLIVYQEFQFNS-UHFFFAOYSA-N (5-methyl-1,2-oxazol-3-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound O1C(C)=CC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=N1 AFVLIVYQEFQFNS-UHFFFAOYSA-N 0.000 claims 1
- NODDZULLAUOZOH-UHFFFAOYSA-N (5-methyl-1,2-oxazol-3-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound O1C(C)=CC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=N1 NODDZULLAUOZOH-UHFFFAOYSA-N 0.000 claims 1
- MKJLTHSGTKCEFT-UHFFFAOYSA-N (5-methyl-1,2-oxazol-4-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound O1N=CC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1C MKJLTHSGTKCEFT-UHFFFAOYSA-N 0.000 claims 1
- JAHIKQHAYSKNEB-UHFFFAOYSA-N (5-methyl-1,2-oxazol-4-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound O1N=CC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=C1C JAHIKQHAYSKNEB-UHFFFAOYSA-N 0.000 claims 1
- KDHCJAYKROGLSL-UHFFFAOYSA-N (5-methyl-1,2-thiazol-4-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound S1N=CC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1C KDHCJAYKROGLSL-UHFFFAOYSA-N 0.000 claims 1
- VIZKLZUPUCRISP-UHFFFAOYSA-N (5-methyl-1,2-thiazol-4-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound S1N=CC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=C1C VIZKLZUPUCRISP-UHFFFAOYSA-N 0.000 claims 1
- YUVRQNUTVZLDCG-UHFFFAOYSA-N (5-methyl-1,3,4-oxadiazol-2-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound O1C(C)=NN=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 YUVRQNUTVZLDCG-UHFFFAOYSA-N 0.000 claims 1
- CDSRJCPKPLSCQX-UHFFFAOYSA-N (5-methyl-1,3,4-oxadiazol-2-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound O1C(C)=NN=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 CDSRJCPKPLSCQX-UHFFFAOYSA-N 0.000 claims 1
- FLFJBXFMMOXOMS-UHFFFAOYSA-N (5-methyl-1,3-thiazol-2-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound S1C(C)=CN=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 FLFJBXFMMOXOMS-UHFFFAOYSA-N 0.000 claims 1
- VCCRPPGFLCLCBR-UHFFFAOYSA-N (5-methyl-1h-1,2,4-triazol-3-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound N1C(C)=NN=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 VCCRPPGFLCLCBR-UHFFFAOYSA-N 0.000 claims 1
- DGALRVDETBRHJK-UHFFFAOYSA-N (5-methyl-1h-pyrazol-4-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound N1N=CC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1C DGALRVDETBRHJK-UHFFFAOYSA-N 0.000 claims 1
- NQHGJYINHULTFT-UHFFFAOYSA-N (5-methyl-1h-pyrazol-4-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound N1N=CC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=C1C NQHGJYINHULTFT-UHFFFAOYSA-N 0.000 claims 1
- ZJYUSYKZJXRKQX-UHFFFAOYSA-N (6-methylpyrazin-2-yl)-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound CC1=CN=CC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=N1 ZJYUSYKZJXRKQX-UHFFFAOYSA-N 0.000 claims 1
- IAEWNUXNTNQGLH-UHFFFAOYSA-N (6-methylpyrazin-2-yl)-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound CC1=CN=CC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=N1 IAEWNUXNTNQGLH-UHFFFAOYSA-N 0.000 claims 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 claims 1
- DPSYUZJOMWRBDG-UHFFFAOYSA-N 1,2,5-oxadiazol-3-yl-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C1=NON=C1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 DPSYUZJOMWRBDG-UHFFFAOYSA-N 0.000 claims 1
- 125000004506 1,2,5-oxadiazolyl group Chemical group 0.000 claims 1
- 125000004517 1,2,5-thiadiazolyl group Chemical group 0.000 claims 1
- ALZFRTZSLVIOHQ-UHFFFAOYSA-N 1,2-oxazol-3-yl-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C1=CON=C1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 ALZFRTZSLVIOHQ-UHFFFAOYSA-N 0.000 claims 1
- VTPSRPPVPKVUMY-UHFFFAOYSA-N 1,2-oxazol-3-yl-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C1=CON=C1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 VTPSRPPVPKVUMY-UHFFFAOYSA-N 0.000 claims 1
- CKTFFKKQHTYERD-UHFFFAOYSA-N 1,2-oxazol-5-yl-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C=1C=NOC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 CKTFFKKQHTYERD-UHFFFAOYSA-N 0.000 claims 1
- JJIPQPZHFWGODE-UHFFFAOYSA-N 1,2-oxazol-5-yl-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C=1C=NOC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 JJIPQPZHFWGODE-UHFFFAOYSA-N 0.000 claims 1
- 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 claims 1
- SBSOJKXQPPJTRK-UHFFFAOYSA-N 1,3-oxazol-5-yl-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C=1N=COC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 SBSOJKXQPPJTRK-UHFFFAOYSA-N 0.000 claims 1
- SFEHOPOZUFIJEP-UHFFFAOYSA-N 1,3-oxazol-5-yl-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C=1N=COC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 SFEHOPOZUFIJEP-UHFFFAOYSA-N 0.000 claims 1
- FQUYSHZXSKYCSY-UHFFFAOYSA-N 1,4-diazepane Chemical compound C1CNCCNC1 FQUYSHZXSKYCSY-UHFFFAOYSA-N 0.000 claims 1
- RWWFYIUPNHMTCF-UHFFFAOYSA-N 1-[2-oxo-2-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]ethyl]pyrrolidine-2,5-dione Chemical compound C1CCN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1C(=O)CN1C(=O)CCC1=O RWWFYIUPNHMTCF-UHFFFAOYSA-N 0.000 claims 1
- NWBHNMWZKWQZSE-UHFFFAOYSA-N 1-[4-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]piperidin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCC1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 NWBHNMWZKWQZSE-UHFFFAOYSA-N 0.000 claims 1
- JOYRFKOBGRITIF-UHFFFAOYSA-N 1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-2-(1,3-thiazol-4-yl)ethanone Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CC1=CSC=N1 JOYRFKOBGRITIF-UHFFFAOYSA-N 0.000 claims 1
- NJEKBTDTZASQBO-UHFFFAOYSA-N 1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-2-(2h-tetrazol-5-yl)ethanone Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CC1=NN=NN1 NJEKBTDTZASQBO-UHFFFAOYSA-N 0.000 claims 1
- MQNZOHQCFUIRBE-UHFFFAOYSA-N 1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-2-[4-(trifluoromethoxy)phenyl]ethanone Chemical compound C1=CC(OC(F)(F)F)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 MQNZOHQCFUIRBE-UHFFFAOYSA-N 0.000 claims 1
- YQYHIALRGBIGKX-UHFFFAOYSA-N 1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-2-[4-(trifluoromethyl)phenyl]ethanone Chemical compound C1=CC(C(F)(F)F)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 YQYHIALRGBIGKX-UHFFFAOYSA-N 0.000 claims 1
- KAKXGIASPNGBOK-UHFFFAOYSA-N 1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-2-thiophen-2-ylethanone Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CC1=CC=CS1 KAKXGIASPNGBOK-UHFFFAOYSA-N 0.000 claims 1
- QHLHEYWKAVKMMK-UHFFFAOYSA-N 1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]cyclopentane-1-carbonitrile Chemical compound C1CCCC1(C#N)C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 QHLHEYWKAVKMMK-UHFFFAOYSA-N 0.000 claims 1
- LXSLTLFBEUARIJ-UHFFFAOYSA-N 1-[7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.6]nonane-4-carbonyl]cyclopropane-1-carbonitrile Chemical compound C1CC1(C#N)C(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CCC11CC1 LXSLTLFBEUARIJ-UHFFFAOYSA-N 0.000 claims 1
- AXHXEWQDPPULDF-UHFFFAOYSA-N 1-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]-2-(2h-tetrazol-5-yl)ethanone Chemical compound C1CCN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1C(=O)CC1=NN=NN1 AXHXEWQDPPULDF-UHFFFAOYSA-N 0.000 claims 1
- BEBARGCOKWGZCB-UHFFFAOYSA-N 1-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]prop-2-en-1-one Chemical compound C=CC(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 BEBARGCOKWGZCB-UHFFFAOYSA-N 0.000 claims 1
- AXWCMTIPPIOOHC-UHFFFAOYSA-N 1-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonane-4-carbonyl]cyclopropane-1-carbonitrile Chemical compound C1CC1(C#N)C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 AXWCMTIPPIOOHC-UHFFFAOYSA-N 0.000 claims 1
- JZAYAIHDMLAIJR-UHFFFAOYSA-N 1-benzothiophen-2-yl-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C=1C2=CC=CC=C2SC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 JZAYAIHDMLAIJR-UHFFFAOYSA-N 0.000 claims 1
- WFEHCWHEVAJTFA-UHFFFAOYSA-N 1-benzothiophen-2-yl-[7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C=1C2=CC=CC=C2SC=1C(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CCC11CC1 WFEHCWHEVAJTFA-UHFFFAOYSA-N 0.000 claims 1
- IFQHQSKGFKWNLC-UHFFFAOYSA-N 1-methyl-3-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethyl]imidazolidin-2-one Chemical compound O=C1N(C)CCN1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 IFQHQSKGFKWNLC-UHFFFAOYSA-N 0.000 claims 1
- SVYZBIQXXYEUAN-UHFFFAOYSA-N 1-methyl-3-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethyl]imidazolidine-2,4-dione Chemical compound O=C1N(C)CC(=O)N1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 SVYZBIQXXYEUAN-UHFFFAOYSA-N 0.000 claims 1
- CXJGLZBXUCNNSG-UHFFFAOYSA-N 1h-pyrazol-4-yl-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C1=NNC=C1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 CXJGLZBXUCNNSG-UHFFFAOYSA-N 0.000 claims 1
- KVXOVHTUZOWJSY-UHFFFAOYSA-N 1h-pyrazol-5-yl-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C1=CNN=C1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 KVXOVHTUZOWJSY-UHFFFAOYSA-N 0.000 claims 1
- OVIINHYJRZZDIX-UHFFFAOYSA-N 1h-pyrazol-5-yl-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C1=CNN=C1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 OVIINHYJRZZDIX-UHFFFAOYSA-N 0.000 claims 1
- GMCYPCUATFQCQJ-UHFFFAOYSA-N 2,2-dimethyl-3-oxo-3-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]propanenitrile Chemical compound C1N(C(=O)C(C)(C#N)C)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 GMCYPCUATFQCQJ-UHFFFAOYSA-N 0.000 claims 1
- KCXCINIVKGRICP-UHFFFAOYSA-N 2-(1-methylpyrazol-4-yl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound C1=NN(C)C=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 KCXCINIVKGRICP-UHFFFAOYSA-N 0.000 claims 1
- QBPWXMGNPIYEAZ-UHFFFAOYSA-N 2-(1h-imidazol-5-yl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CC1=CN=CN1 QBPWXMGNPIYEAZ-UHFFFAOYSA-N 0.000 claims 1
- WBVTYQYXDWILLJ-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound ClC1=CC(Cl)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 WBVTYQYXDWILLJ-UHFFFAOYSA-N 0.000 claims 1
- MBELEBXDEVCUCV-UHFFFAOYSA-N 2-(2-chlorophenyl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound ClC1=CC=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 MBELEBXDEVCUCV-UHFFFAOYSA-N 0.000 claims 1
- BJOVVSXLSZSBGL-UHFFFAOYSA-N 2-(2-chlorophenyl)-1-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]ethanone Chemical compound ClC1=CC=CC=C1CC(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 BJOVVSXLSZSBGL-UHFFFAOYSA-N 0.000 claims 1
- CTSRQGGWNQDOLN-UHFFFAOYSA-N 2-(2-methyl-1,3-thiazol-4-yl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound S1C(C)=NC(CC(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 CTSRQGGWNQDOLN-UHFFFAOYSA-N 0.000 claims 1
- IWLZUCXLJWPXLD-UHFFFAOYSA-N 2-(2-methyl-1,3-thiazol-5-yl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound S1C(C)=NC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 IWLZUCXLJWPXLD-UHFFFAOYSA-N 0.000 claims 1
- KUQZSAKFPQCDEC-UHFFFAOYSA-N 2-(3-methyl-1,2-oxazol-5-yl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound O1N=C(C)C=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 KUQZSAKFPQCDEC-UHFFFAOYSA-N 0.000 claims 1
- SGDRQXJHLPKJRC-UHFFFAOYSA-N 2-(3-methyl-1,2-oxazol-5-yl)-1-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]ethanone Chemical compound O1N=C(C)C=C1CC(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 SGDRQXJHLPKJRC-UHFFFAOYSA-N 0.000 claims 1
- BEZLLNHHZNLYMN-UHFFFAOYSA-N 2-(3-methylphenyl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound CC1=CC=CC(CC(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 BEZLLNHHZNLYMN-UHFFFAOYSA-N 0.000 claims 1
- MFRMSWBJWRHLDT-UHFFFAOYSA-N 2-(4-bromophenyl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound C1=CC(Br)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 MFRMSWBJWRHLDT-UHFFFAOYSA-N 0.000 claims 1
- BZISCGNPZMCVJS-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound C1=CC(Cl)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 BZISCGNPZMCVJS-UHFFFAOYSA-N 0.000 claims 1
- AVTOPYVLTYPYKG-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]ethanone Chemical compound C1=CC(Cl)=CC=C1CC(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 AVTOPYVLTYPYKG-UHFFFAOYSA-N 0.000 claims 1
- DZHVIOWWDYGDMH-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound C1=CC(F)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 DZHVIOWWDYGDMH-UHFFFAOYSA-N 0.000 claims 1
- WWEUZIWOUJYRSW-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]ethanone Chemical compound C1=CC(F)=CC=C1CC(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 WWEUZIWOUJYRSW-UHFFFAOYSA-N 0.000 claims 1
- DUOZNEDGQOSJQD-UHFFFAOYSA-N 2-(4-iodophenyl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound C1=CC(I)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 DUOZNEDGQOSJQD-UHFFFAOYSA-N 0.000 claims 1
- FEGZFYMQEPOERJ-UHFFFAOYSA-N 2-(4-methoxyphenyl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound C1=CC(OC)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 FEGZFYMQEPOERJ-UHFFFAOYSA-N 0.000 claims 1
- HDPSLTXIGWEHLC-UHFFFAOYSA-N 2-(4-methyl-1,3-thiazol-5-yl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound N1=CSC(CC(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1C HDPSLTXIGWEHLC-UHFFFAOYSA-N 0.000 claims 1
- YIBZISHPSURFEJ-UHFFFAOYSA-N 2-(4-methylphenyl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound C1=CC(C)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 YIBZISHPSURFEJ-UHFFFAOYSA-N 0.000 claims 1
- CYPMHRFGPWKKHI-UHFFFAOYSA-N 2-(4-tert-butylphenyl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound C1=CC(C(C)(C)C)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 CYPMHRFGPWKKHI-UHFFFAOYSA-N 0.000 claims 1
- CJMJPFQGPYLSTJ-UHFFFAOYSA-N 2-(5-methyl-1,2-oxazol-3-yl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound O1C(C)=CC(CC(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=N1 CJMJPFQGPYLSTJ-UHFFFAOYSA-N 0.000 claims 1
- XLDZAPBBOVUCHW-UHFFFAOYSA-N 2-(5-methyl-1h-1,2,4-triazol-3-yl)-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound CC1=NNC(CC(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=N1 XLDZAPBBOVUCHW-UHFFFAOYSA-N 0.000 claims 1
- JOWCYXOUPVKFOD-UHFFFAOYSA-N 2-[2-[7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.6]nonane-4-carbonyl]phenyl]acetonitrile Chemical compound C=1C=CC=C(CC#N)C=1C(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CCC11CC1 JOWCYXOUPVKFOD-UHFFFAOYSA-N 0.000 claims 1
- DMZDZGWYGFXSTG-UHFFFAOYSA-N 2-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethyl]benzonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CC1=CC=CC=C1C#N DMZDZGWYGFXSTG-UHFFFAOYSA-N 0.000 claims 1
- QDVFIXQODCSACJ-UHFFFAOYSA-N 2-[3-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethyl]phenoxy]acetonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CC1=CC=CC(OCC#N)=C1 QDVFIXQODCSACJ-UHFFFAOYSA-N 0.000 claims 1
- HEUCMRDGOHBMJX-UHFFFAOYSA-N 2-[3-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]phenoxy]acetonitrile Chemical compound C=1C=CC(OCC#N)=CC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 HEUCMRDGOHBMJX-UHFFFAOYSA-N 0.000 claims 1
- TXYMQUAKHRLZII-UHFFFAOYSA-N 2-[4-(dimethylamino)phenyl]-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound C1=CC(N(C)C)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 TXYMQUAKHRLZII-UHFFFAOYSA-N 0.000 claims 1
- AZYGJCQUIORHKE-UHFFFAOYSA-N 2-[4-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethyl]phenoxy]acetonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CC1=CC=C(OCC#N)C=C1 AZYGJCQUIORHKE-UHFFFAOYSA-N 0.000 claims 1
- ZCUVKTWNJVYYCD-UHFFFAOYSA-N 2-[4-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethyl]phenyl]acetonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CC1=CC=C(CC#N)C=C1 ZCUVKTWNJVYYCD-UHFFFAOYSA-N 0.000 claims 1
- DKSWLLYECWPXOZ-UHFFFAOYSA-N 2-[4-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]phenoxy]acetonitrile Chemical compound C=1C=C(OCC#N)C=CC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 DKSWLLYECWPXOZ-UHFFFAOYSA-N 0.000 claims 1
- WTQJCZLTBQTFGI-UHFFFAOYSA-N 2-[4-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]phenyl]acetonitrile Chemical compound C=1C=C(CC#N)C=CC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 WTQJCZLTBQTFGI-UHFFFAOYSA-N 0.000 claims 1
- MMTSWYCKIUOVIK-UHFFFAOYSA-N 2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]-1h-indole-5-carbonitrile Chemical compound C=1C2=CC(C#N)=CC=C2NC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 MMTSWYCKIUOVIK-UHFFFAOYSA-N 0.000 claims 1
- JZAADZSZWCMNRK-UHFFFAOYSA-N 2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]-1h-indole-5-sulfonamide Chemical compound C=1C2=CC(S(=O)(=O)N)=CC=C2NC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 JZAADZSZWCMNRK-UHFFFAOYSA-N 0.000 claims 1
- YORHUEBLHQHGRF-UHFFFAOYSA-N 2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]benzonitrile Chemical compound C=1C=CC=C(C#N)C=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 YORHUEBLHQHGRF-UHFFFAOYSA-N 0.000 claims 1
- SHAYRGPBIFHFOY-UHFFFAOYSA-N 2-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonane-4-carbonyl]benzonitrile Chemical compound C=1C=CC=C(C#N)C=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 SHAYRGPBIFHFOY-UHFFFAOYSA-N 0.000 claims 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 claims 1
- NCNOYNYUSKGOLM-UHFFFAOYSA-N 2-cyclopentyl-1-[7-methyl-5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound C1N(C(=O)CC2CCCC2)C(C)CN(C=2C=3C=CNC=3N=CN=2)CC21CC2 NCNOYNYUSKGOLM-UHFFFAOYSA-N 0.000 claims 1
- HTOXFEOYMDCSDL-UHFFFAOYSA-N 2-cyclopentyl-1-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]ethanethione Chemical compound C1CCN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1C(=S)CC1CCCC1 HTOXFEOYMDCSDL-UHFFFAOYSA-N 0.000 claims 1
- MJVIGAVPXOVFIY-UHFFFAOYSA-N 2-cyclopentyl-1-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]ethanone Chemical compound C1CCN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1C(=O)CC1CCCC1 MJVIGAVPXOVFIY-UHFFFAOYSA-N 0.000 claims 1
- LBHYKFUVXUEBQC-UHFFFAOYSA-N 2-fluoro-4-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]benzonitrile Chemical compound C1=C(C#N)C(F)=CC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 LBHYKFUVXUEBQC-UHFFFAOYSA-N 0.000 claims 1
- YFQGHFASHBJJEG-UHFFFAOYSA-N 2-fluoro-5-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethyl]benzonitrile Chemical compound C1=C(C#N)C(F)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 YFQGHFASHBJJEG-UHFFFAOYSA-N 0.000 claims 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- BVMJACQALYTFFU-UHFFFAOYSA-N 2-methyl-5-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonane-4-carbonyl]-1h-pyrrole-3-carbonitrile Chemical compound N#CC1=C(C)NC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=C1 BVMJACQALYTFFU-UHFFFAOYSA-N 0.000 claims 1
- BAVWCDJXFJCZSQ-UHFFFAOYSA-N 2-naphthalen-2-yl-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound C=1C=C2C=CC=CC2=CC=1CC(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 BAVWCDJXFJCZSQ-UHFFFAOYSA-N 0.000 claims 1
- YKJKWRZGAKPQLW-UHFFFAOYSA-N 2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-n-(4-sulfamoylphenyl)acetamide Chemical compound C1=CC(S(=O)(=O)N)=CC=C1NC(=O)C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 YKJKWRZGAKPQLW-UHFFFAOYSA-N 0.000 claims 1
- UDSUTJCXZJKFPE-UHFFFAOYSA-N 2-phenyl-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethanone Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CC1=CC=CC=C1 UDSUTJCXZJKFPE-UHFFFAOYSA-N 0.000 claims 1
- LDEXUKJAAZNEHD-UHFFFAOYSA-N 2-phenyl-1-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]propan-1-one Chemical compound C=1C=CC=CC=1C(C)C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 LDEXUKJAAZNEHD-UHFFFAOYSA-N 0.000 claims 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- UBYSCPNFMLYRSC-UHFFFAOYSA-N 3-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethoxy]benzonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)COC1=CC=CC(C#N)=C1 UBYSCPNFMLYRSC-UHFFFAOYSA-N 0.000 claims 1
- KNECVDPVOUQCOZ-UHFFFAOYSA-N 3-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethyl]-1,3-thiazolidine-2,4-dione Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CN1C(=O)CSC1=O KNECVDPVOUQCOZ-UHFFFAOYSA-N 0.000 claims 1
- WTVMLJQWIOIZTD-UHFFFAOYSA-N 3-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethyl]benzonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CC1=CC=CC(C#N)=C1 WTVMLJQWIOIZTD-UHFFFAOYSA-N 0.000 claims 1
- TUFXUSCMLJSKDJ-UHFFFAOYSA-N 3-[2-oxo-2-[7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.6]nonan-4-yl]ethyl]benzonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CCC2(CC2)N1C(=O)CC1=CC=CC(C#N)=C1 TUFXUSCMLJSKDJ-UHFFFAOYSA-N 0.000 claims 1
- SHLLYLGXDCJEGG-UHFFFAOYSA-N 3-[2-oxo-2-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]ethyl]-1,3-thiazolidine-2,4-dione Chemical compound C1CCN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1C(=O)CN1C(=O)CSC1=O SHLLYLGXDCJEGG-UHFFFAOYSA-N 0.000 claims 1
- UHWVLSDSDAQKFW-UHFFFAOYSA-N 3-[2-oxo-2-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]ethyl]benzonitrile Chemical compound C1CCN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1C(=O)CC1=CC=CC(C#N)=C1 UHWVLSDSDAQKFW-UHFFFAOYSA-N 0.000 claims 1
- ANSNLAIUGKPVSK-UHFFFAOYSA-N 3-[3-oxo-3-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]propyl]benzonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CCC1=CC=CC(C#N)=C1 ANSNLAIUGKPVSK-UHFFFAOYSA-N 0.000 claims 1
- VXSTTYSJCNYZOQ-UHFFFAOYSA-N 3-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]benzonitrile Chemical compound C=1C=CC(C#N)=CC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 VXSTTYSJCNYZOQ-UHFFFAOYSA-N 0.000 claims 1
- VCHXVTNIGYOQTN-UHFFFAOYSA-N 3-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonane-4-carbonyl]benzonitrile Chemical compound C=1C=CC(C#N)=CC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 VCHXVTNIGYOQTN-UHFFFAOYSA-N 0.000 claims 1
- AXZGQISSXNEJMB-UHFFFAOYSA-N 3-oxo-3-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]propanenitrile Chemical compound C1N(C(CC#N)=O)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 AXZGQISSXNEJMB-UHFFFAOYSA-N 0.000 claims 1
- DUGDWKTUPKRZEX-UHFFFAOYSA-N 4,4,4-trifluoro-1-[7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.6]nonan-4-yl]butan-1-one Chemical compound FC(F)(F)CCC(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CCC11CC1 DUGDWKTUPKRZEX-UHFFFAOYSA-N 0.000 claims 1
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical compound C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 claims 1
- ITSKXLYWJKOIPO-UHFFFAOYSA-N 4-(4,7-diazaspiro[2.6]nonan-7-yl)-7h-pyrrolo[2,3-d]pyrimidine;4-(5,8-diazaspiro[2.6]nonan-8-yl)-7h-pyrrolo[2,3-d]pyrimidine Chemical compound C1CC11CN(C=2C=3C=CNC=3N=CN=2)CCNC1.C1CC11NCCN(C=2C=3C=CNC=3N=CN=2)CC1 ITSKXLYWJKOIPO-UHFFFAOYSA-N 0.000 claims 1
- OFMICAWZHSDRBJ-UHFFFAOYSA-N 4-(4-benzyl-4,8-diazaspiro[2.6]nonan-8-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-amine;4-(5-benzyl-5,8-diazaspiro[2.6]nonan-8-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-amine Chemical compound C=12C=CNC2=NC(N)=NC=1N(CC12CC2)CCCN1CC1=CC=CC=C1.C=12C=CNC2=NC(N)=NC=1N(CC1(CC1)C1)CCN1CC1=CC=CC=C1 OFMICAWZHSDRBJ-UHFFFAOYSA-N 0.000 claims 1
- SKUFZDVGRPYKRC-UHFFFAOYSA-N 4-(8-butylsulfonyl-5,8-diazaspiro[2.6]nonan-5-yl)-7h-pyrrolo[2,3-d]pyrimidine;4-[8-(4-methylphenyl)sulfonyl-5,8-diazaspiro[2.6]nonan-5-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound C1N(S(=O)(=O)CCCC)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2.C1=CC(C)=CC=C1S(=O)(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 SKUFZDVGRPYKRC-UHFFFAOYSA-N 0.000 claims 1
- DUQUTVAJSPYMTO-ZZXKWVIFSA-N 4-[(e)-3-oxo-3-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]prop-1-enyl]benzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N)=CC=C1\C=C\C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 DUQUTVAJSPYMTO-ZZXKWVIFSA-N 0.000 claims 1
- PCYJWWXFMNAYOE-AATRIKPKSA-N 4-[(e)-3-oxo-3-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]prop-1-enyl]benzonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)\C=C\C1=CC=C(C#N)C=C1 PCYJWWXFMNAYOE-AATRIKPKSA-N 0.000 claims 1
- FEAAGLGMPJTAMA-UHFFFAOYSA-N 4-[1,1-difluoro-2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethyl]benzonitrile Chemical compound C=1C=C(C#N)C=CC=1C(F)(F)C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 FEAAGLGMPJTAMA-UHFFFAOYSA-N 0.000 claims 1
- XPPGEURUEXMYCB-UHFFFAOYSA-N 4-[2-[7-methyl-5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-2-oxoethyl]benzonitrile Chemical compound C1N(C(=O)CC=2C=CC(=CC=2)C#N)C(C)CN(C=2C=3C=CNC=3N=CN=2)CC21CC2 XPPGEURUEXMYCB-UHFFFAOYSA-N 0.000 claims 1
- OXTVGRBBFWIGGX-UHFFFAOYSA-N 4-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]acetyl]benzonitrile Chemical compound C=1C=C(C#N)C=CC=1C(=O)C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 OXTVGRBBFWIGGX-UHFFFAOYSA-N 0.000 claims 1
- SIHJCKPKMZXQMV-UHFFFAOYSA-N 4-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethoxy]benzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N)=CC=C1OCC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 SIHJCKPKMZXQMV-UHFFFAOYSA-N 0.000 claims 1
- OYKNGEWJSIRZDY-UHFFFAOYSA-N 4-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethyl]benzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 OYKNGEWJSIRZDY-UHFFFAOYSA-N 0.000 claims 1
- QXWYOUFCDBINFP-UHFFFAOYSA-N 4-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethyl]benzonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CC1=CC=C(C#N)C=C1 QXWYOUFCDBINFP-UHFFFAOYSA-N 0.000 claims 1
- ZYOUQYVQPHGSIW-UHFFFAOYSA-N 4-[2-oxo-2-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]ethyl]benzonitrile Chemical compound C1CCN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1C(=O)CC1=CC=C(C#N)C=C1 ZYOUQYVQPHGSIW-UHFFFAOYSA-N 0.000 claims 1
- HEDWYRMXPXZSLI-UHFFFAOYSA-N 4-[3-oxo-3-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]propyl]benzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N)=CC=C1CCC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 HEDWYRMXPXZSLI-UHFFFAOYSA-N 0.000 claims 1
- VZAPOHMBFPQLTR-UHFFFAOYSA-N 4-[3-oxo-3-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]propyl]benzonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1C(=O)CCC1=CC=C(C#N)C=C1 VZAPOHMBFPQLTR-UHFFFAOYSA-N 0.000 claims 1
- HVBNGMODIMBPQZ-UHFFFAOYSA-N 4-[4-(4-methylphenyl)sulfonyl-4,8-diazaspiro[2.6]nonan-8-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 HVBNGMODIMBPQZ-UHFFFAOYSA-N 0.000 claims 1
- PTIQOEAPJMIEDG-UHFFFAOYSA-N 4-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]-1h-pyridin-2-one Chemical compound C1=NC(O)=CC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 PTIQOEAPJMIEDG-UHFFFAOYSA-N 0.000 claims 1
- XGQVRPZWVYFQED-UHFFFAOYSA-N 4-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]benzonitrile Chemical compound C=1C=C(C#N)C=CC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 XGQVRPZWVYFQED-UHFFFAOYSA-N 0.000 claims 1
- VJENLTNTBZDCJW-UHFFFAOYSA-N 4-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]oxane-4-carbonitrile Chemical compound C1COCCC1(C#N)C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 VJENLTNTBZDCJW-UHFFFAOYSA-N 0.000 claims 1
- DQMBHQQDINOSEH-UHFFFAOYSA-N 4-[7-methyl-8-(4-methylphenyl)sulfonyl-5,8-diazaspiro[2.6]nonan-5-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound C1N(S(=O)(=O)C=2C=CC(C)=CC=2)C(C)CN(C=2C=3C=CNC=3N=CN=2)CC21CC2 DQMBHQQDINOSEH-UHFFFAOYSA-N 0.000 claims 1
- PDWVSPAXGKCIDY-UHFFFAOYSA-N 4-oxo-4-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]butanenitrile Chemical compound C1N(C(CCC#N)=O)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 PDWVSPAXGKCIDY-UHFFFAOYSA-N 0.000 claims 1
- DHYSQXOOZFRUGD-UHFFFAOYSA-N 4-oxo-4-[7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.6]nonan-4-yl]butanenitrile Chemical compound N#CCCC(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CCC11CC1 DHYSQXOOZFRUGD-UHFFFAOYSA-N 0.000 claims 1
- GWZJBKORDOTPRB-UHFFFAOYSA-N 4-oxo-4-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]butanenitrile Chemical compound N#CCCC(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 GWZJBKORDOTPRB-UHFFFAOYSA-N 0.000 claims 1
- YFRQZRCKCQRXLK-UHFFFAOYSA-N 5,6-dihydro-4h-cyclopenta[b]thiophen-2-yl-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C=1C=2CCCC=2SC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 YFRQZRCKCQRXLK-UHFFFAOYSA-N 0.000 claims 1
- SGOPKSLVKJSLJV-UHFFFAOYSA-N 5-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]-1h-pyridin-2-one Chemical compound C1=NC(O)=CC=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 SGOPKSLVKJSLJV-UHFFFAOYSA-N 0.000 claims 1
- HCBZUTXAYMNTPI-UHFFFAOYSA-N 5-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]-1h-pyrrole-3-carbonitrile Chemical compound C=1C(C#N)=CNC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 HCBZUTXAYMNTPI-UHFFFAOYSA-N 0.000 claims 1
- XOJIZBBYAGGSBX-UHFFFAOYSA-N 5-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]thiophene-3-carbonitrile Chemical compound C=1C(C#N)=CSC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 XOJIZBBYAGGSBX-UHFFFAOYSA-N 0.000 claims 1
- KREQPVJMPGQNBB-UHFFFAOYSA-N 5-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonane-4-carbonyl]-1,2-dihydropyrazol-3-one Chemical compound N1C(O)=CC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=N1 KREQPVJMPGQNBB-UHFFFAOYSA-N 0.000 claims 1
- LXJHNBLDBMKEQR-UHFFFAOYSA-N 5-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonane-4-carbonyl]-1h-pyridin-2-one Chemical compound C1=NC(O)=CC=C1C(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CCC1 LXJHNBLDBMKEQR-UHFFFAOYSA-N 0.000 claims 1
- QGKODWWXGROVQW-UHFFFAOYSA-N 5-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonane-4-carbonyl]-1h-pyrrole-3-carbonitrile Chemical compound C=1C(C#N)=CNC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 QGKODWWXGROVQW-UHFFFAOYSA-N 0.000 claims 1
- OTSFSKNCVUGWOH-UHFFFAOYSA-N 5-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonane-4-carbonyl]furan-2-carbonitrile Chemical compound C=1C=C(C#N)OC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 OTSFSKNCVUGWOH-UHFFFAOYSA-N 0.000 claims 1
- YQRNVDYAKHZKBZ-UHFFFAOYSA-N 5-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonane-4-carbonyl]thiophene-2-carbonitrile Chemical compound C=1C=C(C#N)SC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 YQRNVDYAKHZKBZ-UHFFFAOYSA-N 0.000 claims 1
- FMLAFBOXJLEJIJ-UHFFFAOYSA-N 5-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonane-4-carbonyl]thiophene-3-carbonitrile Chemical compound C=1C(C#N)=CSC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 FMLAFBOXJLEJIJ-UHFFFAOYSA-N 0.000 claims 1
- YVVHMUZVNFISQM-UHFFFAOYSA-N 6-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]-1h-pyridin-2-one Chemical compound OC1=CC=CC(C(=O)N2CC3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=N1 YVVHMUZVNFISQM-UHFFFAOYSA-N 0.000 claims 1
- DSFVMHZUPINIPH-UHFFFAOYSA-N 6-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonane-4-carbonyl]-1h-pyridin-2-one Chemical compound OC1=CC=CC(C(=O)N2C3(CC3)CN(CCC2)C=2C=3C=CNC=3N=CN=2)=N1 DSFVMHZUPINIPH-UHFFFAOYSA-N 0.000 claims 1
- SQWCUGDEYIHOQD-UHFFFAOYSA-N 7-methyl-n-phenyl-5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carboxamide Chemical compound C1N(C(=O)NC=2C=CC=CC=2)C(C)CN(C=2C=3C=CNC=3N=CN=2)CC21CC2 SQWCUGDEYIHOQD-UHFFFAOYSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 1
- 208000026872 Addison Disease Diseases 0.000 claims 1
- 201000004384 Alopecia Diseases 0.000 claims 1
- 206010002198 Anaphylactic reaction Diseases 0.000 claims 1
- 206010003694 Atrophy Diseases 0.000 claims 1
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 claims 1
- 208000033222 Biliary cirrhosis primary Diseases 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 206010010741 Conjunctivitis Diseases 0.000 claims 1
- 206010012442 Dermatitis contact Diseases 0.000 claims 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 201000005569 Gout Diseases 0.000 claims 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 claims 1
- 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 claims 1
- 101000844245 Homo sapiens Non-receptor tyrosine-protein kinase TYK2 Proteins 0.000 claims 1
- 101000997835 Homo sapiens Tyrosine-protein kinase JAK1 Proteins 0.000 claims 1
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 claims 1
- 101000934996 Homo sapiens Tyrosine-protein kinase JAK3 Proteins 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 102000042838 JAK family Human genes 0.000 claims 1
- 108091082332 JAK family Proteins 0.000 claims 1
- 102100032028 Non-receptor tyrosine-protein kinase TYK2 Human genes 0.000 claims 1
- 208000022873 Ocular disease Diseases 0.000 claims 1
- 201000011152 Pemphigus Diseases 0.000 claims 1
- 208000031845 Pernicious anaemia Diseases 0.000 claims 1
- 208000012654 Primary biliary cholangitis Diseases 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 1
- 206010039705 Scleritis Diseases 0.000 claims 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 206010040799 Skin atrophy Diseases 0.000 claims 1
- 206010042742 Sympathetic ophthalmia Diseases 0.000 claims 1
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 claims 1
- 102100025387 Tyrosine-protein kinase JAK3 Human genes 0.000 claims 1
- 208000024780 Urticaria Diseases 0.000 claims 1
- 206010046851 Uveitis Diseases 0.000 claims 1
- WBANWZRSECFVBP-UHFFFAOYSA-N [5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-(1,2,5-thiadiazol-3-yl)methanone Chemical compound C1=NSN=C1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 WBANWZRSECFVBP-UHFFFAOYSA-N 0.000 claims 1
- HTLLKUXKXFDMTR-UHFFFAOYSA-N [5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-(1,2-thiazol-3-yl)methanone Chemical compound C1=CSN=C1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 HTLLKUXKXFDMTR-UHFFFAOYSA-N 0.000 claims 1
- QGVTWLOGCYSNHS-UHFFFAOYSA-N [5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-(1,2-thiazol-4-yl)methanone Chemical compound C1=NSC=C1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 QGVTWLOGCYSNHS-UHFFFAOYSA-N 0.000 claims 1
- VHVJNUDZUFWXKG-UHFFFAOYSA-N [5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-(1,2-thiazol-5-yl)methanone Chemical compound C=1C=NSC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 VHVJNUDZUFWXKG-UHFFFAOYSA-N 0.000 claims 1
- KPEDHYOYVSXPDA-UHFFFAOYSA-N [5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-(1,3-thiazol-4-yl)methanone Chemical compound C=1SC=NC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 KPEDHYOYVSXPDA-UHFFFAOYSA-N 0.000 claims 1
- AZEKJDYQVJPNAO-UHFFFAOYSA-N [5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-(1,3-thiazol-5-yl)methanone Chemical compound C=1N=CSC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 AZEKJDYQVJPNAO-UHFFFAOYSA-N 0.000 claims 1
- LUNRKOHPBGNTIB-UHFFFAOYSA-N [5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-(1h-1,2,4-triazol-5-yl)methanone Chemical compound N1=CNN=C1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 LUNRKOHPBGNTIB-UHFFFAOYSA-N 0.000 claims 1
- IOBNLEWTCCMBLE-UHFFFAOYSA-N [5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-(2h-triazol-4-yl)methanone Chemical compound C=1NN=NC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 IOBNLEWTCCMBLE-UHFFFAOYSA-N 0.000 claims 1
- XCVAAQNNQVDELY-UHFFFAOYSA-N [7-methyl-5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]-phenylmethanone Chemical compound C1N(C(=O)C=2C=CC=CC=2)C(C)CN(C=2C=3C=CNC=3N=CN=2)CC21CC2 XCVAAQNNQVDELY-UHFFFAOYSA-N 0.000 claims 1
- RTOTWCAXGLICED-UHFFFAOYSA-N [8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]-(1,2,5-thiadiazol-3-yl)methanone Chemical compound C1=NSN=C1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 RTOTWCAXGLICED-UHFFFAOYSA-N 0.000 claims 1
- POKAUZMNUVSZJD-UHFFFAOYSA-N [8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]-(1,2-thiazol-3-yl)methanone Chemical compound C1=CSN=C1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 POKAUZMNUVSZJD-UHFFFAOYSA-N 0.000 claims 1
- FQVVGKVTOJAHCL-UHFFFAOYSA-N [8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]-(1,2-thiazol-4-yl)methanone Chemical compound C1=NSC=C1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 FQVVGKVTOJAHCL-UHFFFAOYSA-N 0.000 claims 1
- HQXAEBGKJOTZOB-UHFFFAOYSA-N [8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]-(1,2-thiazol-5-yl)methanone Chemical compound C=1C=NSC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 HQXAEBGKJOTZOB-UHFFFAOYSA-N 0.000 claims 1
- OQOHVKOMCSDWGV-UHFFFAOYSA-N [8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]-(1,3-thiazol-4-yl)methanone Chemical compound C=1SC=NC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 OQOHVKOMCSDWGV-UHFFFAOYSA-N 0.000 claims 1
- NRSBNRQUBMLTQJ-UHFFFAOYSA-N [8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]-(1,3-thiazol-5-yl)methanone Chemical compound C=1N=CSC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 NRSBNRQUBMLTQJ-UHFFFAOYSA-N 0.000 claims 1
- JJTGEGBHEOAPIQ-UHFFFAOYSA-N [8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]-(1h-1,2,4-triazol-5-yl)methanone Chemical compound N1=CNN=C1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 JJTGEGBHEOAPIQ-UHFFFAOYSA-N 0.000 claims 1
- AMXUZNHLEZEFEH-UHFFFAOYSA-N [8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]-(1h-pyrrol-2-yl)methanone Chemical compound C=1C=CNC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 AMXUZNHLEZEFEH-UHFFFAOYSA-N 0.000 claims 1
- DROOMERGIJPSHN-UHFFFAOYSA-N [8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]-(2h-triazol-4-yl)methanone Chemical compound C=1NN=NC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 DROOMERGIJPSHN-UHFFFAOYSA-N 0.000 claims 1
- NXWYHGJLLZHPMK-UHFFFAOYSA-N [8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]-(thiadiazol-4-yl)methanone Chemical compound C=1SN=NC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 NXWYHGJLLZHPMK-UHFFFAOYSA-N 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 206010069351 acute lung injury Diseases 0.000 claims 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 1
- 230000032683 aging Effects 0.000 claims 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000000172 allergic effect Effects 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 231100000360 alopecia Toxicity 0.000 claims 1
- 230000036783 anaphylactic response Effects 0.000 claims 1
- 208000003455 anaphylaxis Diseases 0.000 claims 1
- 230000037444 atrophy Effects 0.000 claims 1
- 201000005000 autoimmune gastritis Diseases 0.000 claims 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 208000010217 blepharitis Diseases 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000030949 chronic idiopathic urticaria Diseases 0.000 claims 1
- 208000037976 chronic inflammation Diseases 0.000 claims 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 1
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 claims 1
- 206010072757 chronic spontaneous urticaria Diseases 0.000 claims 1
- 208000024376 chronic urticaria Diseases 0.000 claims 1
- 208000010247 contact dermatitis Diseases 0.000 claims 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- OMXSCDWJAZPSQB-UHFFFAOYSA-N cyclohexyl-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C1CCN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1C(=O)C1CCCCC1 OMXSCDWJAZPSQB-UHFFFAOYSA-N 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 208000033679 diabetic kidney disease Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000002632 imidazolidinyl group Chemical group 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 201000004614 iritis Diseases 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000001786 isothiazolyl group Chemical group 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 230000007803 itching Effects 0.000 claims 1
- 201000010666 keratoconjunctivitis Diseases 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 206010028417 myasthenia gravis Diseases 0.000 claims 1
- HYROABZTGGSPIK-UHFFFAOYSA-N n,n-bis(cyanomethyl)-5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carboxamide Chemical compound C1N(C(N(CC#N)CC#N)=O)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 HYROABZTGGSPIK-UHFFFAOYSA-N 0.000 claims 1
- SJKHYGVQEHKAJS-UHFFFAOYSA-N n,n-diethyl-5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-sulfonamide Chemical compound C1N(S(=O)(=O)N(CC)CC)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 SJKHYGVQEHKAJS-UHFFFAOYSA-N 0.000 claims 1
- KIZUUCCIUZSJCA-UHFFFAOYSA-N n-(2-cyanoethyl)-n-ethyl-5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carboxamide Chemical compound C1N(C(=O)N(CCC#N)CC)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 KIZUUCCIUZSJCA-UHFFFAOYSA-N 0.000 claims 1
- DAQRPXKNDPOIKK-UHFFFAOYSA-N n-(2-cyanoethyl)-n-methyl-5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carboxamide Chemical compound C1N(C(=O)N(CCC#N)C)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 DAQRPXKNDPOIKK-UHFFFAOYSA-N 0.000 claims 1
- UZMWVTSQJOIJIX-UHFFFAOYSA-N n-(2-cyanoethyl)-n-methyl-5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-sulfonamide Chemical compound C1N(S(=O)(=O)N(CCC#N)C)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 UZMWVTSQJOIJIX-UHFFFAOYSA-N 0.000 claims 1
- VTDLFUDJTKIXOQ-UHFFFAOYSA-N n-(cyanomethyl)-n-methyl-5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carboxamide Chemical compound C1N(C(=O)N(CC#N)C)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 VTDLFUDJTKIXOQ-UHFFFAOYSA-N 0.000 claims 1
- PPTMGJMFQMXAHT-UHFFFAOYSA-N n-[4-(4-benzyl-4,8-diazaspiro[2.6]nonan-8-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl]pentanamide Chemical compound C=12C=CNC2=NC(NC(=O)CCCC)=NC=1N(CC12CC2)CCCN1CC1=CC=CC=C1 PPTMGJMFQMXAHT-UHFFFAOYSA-N 0.000 claims 1
- YFIPGUGBPDMQND-UHFFFAOYSA-N n-[4-[2-oxo-2-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]ethyl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1CC(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 YFIPGUGBPDMQND-UHFFFAOYSA-N 0.000 claims 1
- IMFMQAPPMAFUBU-UHFFFAOYSA-N n-[4-[4-(2-phenylacetyl)-4,8-diazaspiro[2.6]nonan-8-yl]-7h-pyrrolo[2,3-d]pyrimidin-2-yl]pentanamide Chemical compound C=12C=CNC2=NC(NC(=O)CCCC)=NC=1N(CC12CC2)CCCN1C(=O)CC1=CC=CC=C1 IMFMQAPPMAFUBU-UHFFFAOYSA-N 0.000 claims 1
- WZDNQPLLNQTGMF-UHFFFAOYSA-N n-[4-[4-(5-cyanothiophene-2-carbonyl)-4,8-diazaspiro[2.6]nonan-8-yl]-7h-pyrrolo[2,3-d]pyrimidin-2-yl]pentanamide Chemical compound C=12C=CNC2=NC(NC(=O)CCCC)=NC=1N(CC12CC2)CCCN1C(=O)C1=CC=C(C#N)S1 WZDNQPLLNQTGMF-UHFFFAOYSA-N 0.000 claims 1
- VNRDBLMKWKRDSZ-UHFFFAOYSA-N n-[4-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-carbonyl]phenyl]methanesulfonamide Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1C(=O)N1CC2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 VNRDBLMKWKRDSZ-UHFFFAOYSA-N 0.000 claims 1
- PALZRGTZRHMMLI-UHFFFAOYSA-N n-[4-[8-(5-cyanothiophene-2-carbonyl)-5,8-diazaspiro[2.6]nonan-5-yl]-7h-pyrrolo[2,3-d]pyrimidin-2-yl]pentanamide Chemical compound C=12C=CNC2=NC(NC(=O)CCCC)=NC=1N(C1)CCN(C(=O)C=2SC(=CC=2)C#N)CC21CC2 PALZRGTZRHMMLI-UHFFFAOYSA-N 0.000 claims 1
- DHBGVLNYFZFEGD-UHFFFAOYSA-N n-cyclohexyl-n-methyl-5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonane-8-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)CN1S(=O)(=O)N(C)C1CCCCC1 DHBGVLNYFZFEGD-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 201000001976 pemphigus vulgaris Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000002098 pyridazinyl group Chemical group 0.000 claims 1
- MUUNHZUYFSMPAL-UHFFFAOYSA-N pyridin-2-yl-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C=1C=CC=NC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 MUUNHZUYFSMPAL-UHFFFAOYSA-N 0.000 claims 1
- LUXXBPQTEXODAK-UHFFFAOYSA-N pyridin-2-yl-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C=1C=CC=NC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 LUXXBPQTEXODAK-UHFFFAOYSA-N 0.000 claims 1
- ZAELWLGUWRJFHF-UHFFFAOYSA-N pyridin-3-yl-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C=1C=CN=CC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 ZAELWLGUWRJFHF-UHFFFAOYSA-N 0.000 claims 1
- VCMQAWOGCQORAX-UHFFFAOYSA-N pyridin-3-yl-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C=1C=CN=CC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 VCMQAWOGCQORAX-UHFFFAOYSA-N 0.000 claims 1
- WAVUBNSFMGIPDX-UHFFFAOYSA-N pyridin-4-yl-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C=1C=NC=CC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 WAVUBNSFMGIPDX-UHFFFAOYSA-N 0.000 claims 1
- FVYZSADIOBFWQX-UHFFFAOYSA-N pyridin-4-yl-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C=1C=NC=CC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 FVYZSADIOBFWQX-UHFFFAOYSA-N 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims 1
- HOVLTYONORVAEX-UHFFFAOYSA-N pyrimidin-4-yl-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C=1C=NC=NC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 HOVLTYONORVAEX-UHFFFAOYSA-N 0.000 claims 1
- VCZVJTBPFJPVAJ-UHFFFAOYSA-N pyrimidin-4-yl-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C=1C=NC=NC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 VCZVJTBPFJPVAJ-UHFFFAOYSA-N 0.000 claims 1
- PJNAYZAUVAOZPD-UHFFFAOYSA-N pyrimidin-5-yl-[5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5,8-diazaspiro[2.6]nonan-8-yl]methanone Chemical compound C=1N=CN=CC=1C(=O)N(C1)CCN(C=2C=3C=CNC=3N=CN=2)CC21CC2 PJNAYZAUVAOZPD-UHFFFAOYSA-N 0.000 claims 1
- IWNLGJJECYTURX-UHFFFAOYSA-N pyrimidin-5-yl-[8-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,8-diazaspiro[2.6]nonan-4-yl]methanone Chemical compound C=1N=CN=CC=1C(=O)N1CCCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 IWNLGJJECYTURX-UHFFFAOYSA-N 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 208000008742 seborrheic dermatitis Diseases 0.000 claims 1
- 230000009759 skin aging Effects 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 1
- 125000001984 thiazolidinyl group Chemical group 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000005302 thiazolylmethyl group Chemical group [H]C1=C([H])N=C(S1)C([H])([H])* 0.000 claims 1
- 125000005301 thienylmethyl group Chemical group [H]C1=C([H])C([H])=C(S1)C([H])([H])* 0.000 claims 1
- BWJZHYWAXLWLTB-UHFFFAOYSA-N thiophene-3-sulfonamide Chemical compound NS(=O)(=O)C=1C=CSC=1 BWJZHYWAXLWLTB-UHFFFAOYSA-N 0.000 claims 1
- 210000001685 thyroid gland Anatomy 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36309510P | 2010-07-09 | 2010-07-09 | |
| US61/363,095 | 2010-07-09 | ||
| PCT/DK2011/000080 WO2012003829A1 (en) | 2010-07-09 | 2011-07-08 | Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2013105450A true RU2013105450A (ru) | 2014-08-20 |
Family
ID=44513700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013105450/04A RU2013105450A (ru) | 2010-07-09 | 2011-07-08 | Новые производные гомопиперзина в качестве ингибиторов протеинтирозинкиназ и их фармацевтическое применение |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9586961B2 (https=) |
| EP (1) | EP2590981B1 (https=) |
| JP (1) | JP2013533868A (https=) |
| CN (1) | CN102985425A (https=) |
| RU (1) | RU2013105450A (https=) |
| TW (1) | TW201204732A (https=) |
| WO (1) | WO2012003829A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104072499A (zh) * | 2013-03-29 | 2014-10-01 | 黄传满 | 哌嗪取代嘧啶类化合物及其用途 |
| CN103242321A (zh) * | 2013-05-21 | 2013-08-14 | 苏州科捷生物医药有限公司 | 苄基哌嗪类化合物及其抗肿瘤用途 |
| CN103396414B (zh) * | 2013-07-16 | 2015-06-03 | 浙江医药高等专科学校 | 咪唑取代的噻唑并环己烷类化合物、及其抗肿瘤用途 |
| SI3077395T1 (en) * | 2013-12-05 | 2018-03-30 | Pfizer Inc. | Pyrrolo(2,3-d)pyrimidinyl, pyrrolo(2,3-b)pyrazinyl and pyrrolo(2,3-d)pyridinyl acrylamides |
| AR101214A1 (es) * | 2014-07-22 | 2016-11-30 | Bayer Cropscience Ag | Ciano-cicloalquilpenta-2,4-dienos, ciano-cicloalquilpent-2-en-4-inas, ciano-heterociclilpenta-2,4-dienos y ciano-heterociclilpent-2-en-4-inas sustituidos como principios activos contra el estrés abiótico de plantas |
| CN105712998B (zh) * | 2014-12-05 | 2019-12-13 | 上海润诺生物科技有限公司 | 氮杂吲哚类衍生物、其制备方法及其在医药上的应用 |
| EP3512857B1 (en) * | 2016-09-14 | 2021-02-24 | Janssen Pharmaceutica NV | Spiro bicyclic inhibitors of menin-mll interaction |
| WO2018134352A1 (en) * | 2017-01-20 | 2018-07-26 | Leo Pharma A/S | Bicyclic amines as novel jak kinase inhibitors |
| RU2761626C2 (ru) * | 2017-02-03 | 2021-12-13 | Лео Фарма А/С | ПРОИЗВОДНЫЕ 5-(7Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-5-АЗАСПИРО[2.5]ОКТАН-8-КАРБОНОВОЙ КИСЛОТЫ В КАЧЕСТВЕ НОВЫХ ИНГИБИТОРОВ JAK-КИНАЗЫ |
| CN108069986B (zh) * | 2017-12-08 | 2018-10-02 | 牡丹江医学院 | 一种治疗角膜炎的活性药物及其制备方法 |
| WO2020092015A1 (en) | 2018-11-02 | 2020-05-07 | University Of Rochester | Therapeutic mitigation of epithelial infection |
| MX2022002646A (es) | 2019-09-05 | 2022-04-26 | Incyte Corp | Formulacion de ruxolitinib para la reduccion de comezon en dermatitis atopica. |
| US11992490B2 (en) | 2019-10-16 | 2024-05-28 | Incyte Corporation | Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP) |
| TW202525813A (zh) | 2019-12-19 | 2025-07-01 | 比利時商健生藥品公司 | 經取代之直鏈螺環接衍生物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PA8474101A1 (es) * | 1998-06-19 | 2000-09-29 | Pfizer Prod Inc | Compuestos de pirrolo [2,3-d] pirimidina |
| SK286640B6 (sk) * | 1998-06-19 | 2009-03-05 | Pfizer Products Inc. | Pyrol [2,3-d] pyrimidínová zlúčenina, jej použitie na výrobu liečiva, farmaceutická kompozícia s jej obsahom, použitie jej kombinácie s ďalšími činidlami a súpravy s jej obsahom na výrobu liečiva |
| WO2005117909A2 (en) | 2004-04-23 | 2005-12-15 | Exelixis, Inc. | Kinase modulators and methods of use |
| US20090192143A1 (en) | 2006-07-14 | 2009-07-30 | Cox Christopher D | Substituted diazepan orexin receptor antagonists |
| CN101679440A (zh) * | 2007-04-02 | 2010-03-24 | 帕劳制药股份有限公司 | 作为jak3抑制剂的吡咯并嘧啶衍生物 |
| WO2009017838A2 (en) | 2007-08-01 | 2009-02-05 | Exelixis, Inc. | Combinations of jak-2 inhibitors and other agents |
| DK2188289T3 (en) * | 2007-08-08 | 2016-01-25 | Lexicon Pharmaceuticals Inc | (7H-Pyrrolo [2,3-D] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation |
| PE20091485A1 (es) | 2008-02-06 | 2009-10-26 | Novartis Ag | DERIVADOS DE PIRROLO-[2,3-d]-PIRIMIDINA COMO INHIBIDORES DE CINASAS |
| AU2009238590A1 (en) | 2008-04-22 | 2009-10-29 | Portola Pharmaceuticals, Inc. | Inhibitors of protein kinases |
-
2011
- 2011-07-08 US US13/809,059 patent/US9586961B2/en not_active Expired - Fee Related
- 2011-07-08 JP JP2013517018A patent/JP2013533868A/ja active Pending
- 2011-07-08 RU RU2013105450/04A patent/RU2013105450A/ru not_active Application Discontinuation
- 2011-07-08 TW TW100124316A patent/TW201204732A/zh unknown
- 2011-07-08 WO PCT/DK2011/000080 patent/WO2012003829A1/en not_active Ceased
- 2011-07-08 CN CN2011800339890A patent/CN102985425A/zh active Pending
- 2011-07-08 EP EP11738151.7A patent/EP2590981B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| TW201204732A (en) | 2012-02-01 |
| CN102985425A (zh) | 2013-03-20 |
| US20130172325A1 (en) | 2013-07-04 |
| EP2590981B1 (en) | 2014-09-03 |
| US9586961B2 (en) | 2017-03-07 |
| WO2012003829A1 (en) | 2012-01-12 |
| JP2013533868A (ja) | 2013-08-29 |
| EP2590981A1 (en) | 2013-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2013105450A (ru) | Новые производные гомопиперзина в качестве ингибиторов протеинтирозинкиназ и их фармацевтическое применение | |
| JP2013533868A5 (https=) | ||
| JP5918217B2 (ja) | 特定のアミノピリダジン、その組成物、及びこれらの使用方法 | |
| US9493446B2 (en) | Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives | |
| ES2536191T3 (es) | Derivados de sulfonamida | |
| JP5412429B2 (ja) | 抗細菌性アミド及びスルホンアミド置換複素環式尿素化合物 | |
| JP2011503166A5 (https=) | ||
| JP2010533158A5 (https=) | ||
| WO2017087905A1 (en) | Compound, compositions, and methods | |
| CA2610888A1 (en) | Inhibitors of akt activity | |
| ES2573831T3 (es) | Derivados de oxazol y tiazol como inhibidores selectivos de la proteína quinasa (C-kit) | |
| RU2013155456A (ru) | Соединения пирролидинилмочевины и пирролидинилтиомочевины как ингибиторы киназы trka | |
| EP2688872A1 (en) | Amidopyrazole inhibitors of interleukin receptor-associated kinases | |
| JP2016523911A5 (https=) | ||
| ES2807785T3 (es) | Compuestos de heteroarilamina bicíclicos como inhibidores de pi3k | |
| RU2016141646A (ru) | Ингибиторы trka киназы, основанные на них композиции и способы | |
| RU2016102137A (ru) | Первичные карбоксамиды в качестве ингибиторов bik | |
| HRP20230789T1 (hr) | Derivati benzhidroksamske kiseline kao selektivni inhibitori hdac6 | |
| IL295076B1 (en) | Piperidinone derivatives as MDM2 inhibitors for cancer treatment | |
| RU2005121494A (ru) | Тиенопиримидиндионы и их применение в модулировании аутоиммунного заболевания | |
| RU2011116230A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы | |
| CA2554310A1 (en) | Benzamide derivatives and their use as glucokinase activating agents | |
| AU2003292444A1 (en) | Therapeutic applications of 2-substituted 4-heteroarylryrimidines | |
| HRP20200440T1 (hr) | 1h-pirazolo[4,3-b]piridini kao pde1 inhibitori | |
| RU2013136778A (ru) | Ингибиторы гистондезацетилазы, композиции и способы их применения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20151014 |